[Drugs in shock treatment].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002302:Cardiac Output; D002746:Chlorpromazine / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D012769:Shock / Q000188:drug therapy* / Q000503:physiopathology; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000503:physiopathology; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D004071:Digitalis Glycosides; D010952:Plasma Substitutes; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D007545:Isoproterenol; D002746:Chlorpromazine; D010646:Phentolamine
Die Anwendung von Arzneimitteln bei der Schock-Behandlung.